Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$63.32 USD

63.32
931,004

-0.05 (-0.08%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $63.32 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Instruments - Scientific

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Down -22.53% in 4 Weeks, Here's Why Bruker (BRKR) Looks Ripe for a Turnaround

by Zacks Equity Research

Bruker (BRKR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline

by Zacks Equity Research

Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.

Bruker (BRKR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Are Computer and Technology Stocks Lagging Alphabet (GOOGL) This Year?

by Zacks Equity Research

Here is how Alphabet (GOOGL) and Bruker (BRKR) have performed compared to their sector so far this year.

Bruker (BRKR) Q1 Earnings Beat Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 15.22% and 0.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?

by Urmimala Biswas

Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.

Countdown to Bruker (BRKR) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

by Zacks Equity Research

Evaluate the expected performance of Bruker (BRKR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Here's Why You Should Buy Bruker (BRKR) Stock Right Now

by Zacks Equity Research

Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.

Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid

by Zacks Equity Research

Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.

Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

by Zacks Equity Research

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

by Zacks Equity Research

Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.

Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?

by Zacks Equity Research

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?

by Zacks Equity Research

Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.

Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO

by Zacks Equity Research

Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.

Here's Why Investors Should Retain Bruker (BRKR) Stock Now

by Zacks Equity Research

The strength of the BSI BioSpin and CALID groups bodes well for Bruker (BRKR).

Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup

by Zacks Equity Research

Bruker (BRKR) announces a share purchase agreement to acquire the molecular diagnostics innovator ELITechGroup.

Bruker's (BRKR) New Launches Drive Growth Amid FX Woes

by Zacks Equity Research

Bruker's (BRKR) revenues continue to be driven by the strength of end markets, including academic and government, and industrial.

Zacks Industry Outlook Highlights Mettler-Toledo and Bruker

by Zacks Equity Research

Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

2 Instruments Stocks to Buy From a Prospering Industry

by Aniruddha Ganguly

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.

Bruker (BRKR) Q4 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Strength in BioSpin and CALID groups contributes to Bruker's (BRKR) Q4 revenues.

Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Bruker (BRKR) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 7.69% and 2.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Trade Desk (TTD) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

The Trade Desk's (TTD) fourth-quarter 2023 performance is likely to have benefited from the growing CTV momentum and expanding partner base in the United States.